LANDOS BIOPHARMA
Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.The company's therapeutics are novel, locally-acting small molecules targeting inflammatory bowel disease (IBD), crohn's disease (CD) and ulcerative colitis (UC), enabling healthcare providers to cure their patients.
LANDOS BIOPHARMA
Industry:
Biopharma Biotechnology Clinical Trials Health Care Pharmaceutical Therapeutics
Founded:
2017-06-01
Address:
Blacksburg, Virginia, United States
Country:
United States
Website Url:
http://www.landosbiopharma.com
Total Employee:
11+
Status:
Active
Contact:
(540) 218-2232
Email Addresses:
[email protected]
Total Funding:
70 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Domain Not Resolving
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Navitor Pharmaceuticals
Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Chris Garabedian
Chris Garabedian investment in Series B - Landos Biopharma
Perceptive Advisors
Perceptive Advisors investment in Series B - Landos Biopharma
PBM Capital Group
PBM Capital Group investment in Series B - Landos Biopharma
RTW Investments LLC
RTW Investments LLC investment in Series B - Landos Biopharma
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series B - Landos Biopharma
Helicase Venture
Helicase Venture investment in Series B - Landos Biopharma
Perceptive Advisors
Perceptive Advisors investment in Series A - Landos Biopharma
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-21 | Landos Names Gregory Oakes President and Chief Executive Officer |
Official Site Inspections
http://www.landosbiopharma.com Semrush global rank: 4.94 M Semrush visits lastest month: 1.74 K
- Host name: 159.180.132.176
- IP address: 159.180.132.176
- Location: North Chicago United States
- Latitude: 42.325
- Longitude: -87.8561
- Metro Code: 602
- Timezone: America/Chicago
- Postal: 60064
More informations about "Landos Biopharma"
Landos Biopharma - Crunchbase Company Profile
Contact Email [email protected] Phone Number (540) 218-2232 Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.The company's therapeutics are novel, locally …See details»
Landos Biopharma - AbbVie
We're building on our deep expertise and legacy in immunology research to explore new disease areas, create a more patient-centric discovery and development process and offer solutions …See details»
Landos Biopharma, Inc. - Drug pipelines, Patents, Clinical trials
Www.landosbiopharma.com. Public Company | 2017 | Virginia, United States | 10-50 | NASDAQ: LABP | www.landosbiopharma.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. ...See details»
Landos Biopharma, Inc.
Incorporation or organization) 1800 Kraft Drive, Suite 216 Blacksburg, Virginia (Address of principal executive offices) 81-5085535 (I.R.S. Employer Identification No.) 24060 (Zip Code) …See details»
Landos Biopharma, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Landos Biopharma, Inc. of Roanoke, VA. Get the latest business insights from Dun & Bradstreet.See details»
AbbVie Completes Acquisition of Landos Biopharma
May 23, 2024 - Adds first-in-class investigational asset, NX-13, to AbbVie's pipeline with the potential to offer a novel approach to the treatment of ulcerative colitis (UC) and Crohn's disease (CD) NORTH...See details»
Org Chart Landos Biopharma - The Official Board
Www.landosbiopharma.com. has 11 executives - and belongs to AbbVie +1 540 218 1767; Add an executive. Landos Biopharma (LABP) News . Anything missing? We search for you. Print or download . Board. N-1. N-2 . Chairman …See details»
AbbVie Completes Acquisition of Landos Biopharma - Nasdaq
May 23, 2024 With the completion of the acquisition, Landos is now part of AbbVie. Landos' lead investigational asset is NX-13, a first-in-class, oral NLRX1 agonist, which is currently in Phase …See details»
Landos Biopharma - Products, Competitors, Financials, Employees ...
Headquarters Location. 1800 Kraft Drive Suite 216. Blacksburg, Virginia, 24060, United States. 540-218-1767See details»
Landos Biopharma - Craft
May 23, 2024 Landos Biopharma has 4 employees at their 1 location and $18 m in annual revenue in FY 2021. See insights on Landos Biopharma including office locations, …See details»
Landos Biopharma Company Profile 2024: Valuation, …
Landos Biopharma General Information Description. Landos Biopharma Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases.See details»
Investor Relations - Landos Biopharma
Landos Biopharma is a clinical stage biopharmaceutical company focused on the development of first-in-class, oral therapeutics for patients with autoimmune disease.See details»
COMPANYCORPORATE PRESENTATION | JULY …
4 LandosLeadership Team Dr. Josep Bassaganya-Riera Chairman of the Board, President, and CEO Biotech entrepreneur and innovator with 25 years of scientific innovation in immunology, …See details»
Landos Biopharma - Overview, News & Competitors | ZoomInfo.com
Landos Biopharma contact info: Phone number: (540) 218-2232 Website: www.landosbiopharma.com What does Landos Biopharma do? Landos Biopharma, Inc., a …See details»
Landos Biopharma Company Profile | Management and …
[email protected]: Landos Biopharma Top Competitors. Company Employees Revenue Top technologies; Alzheon Inc. 16: $3.8 M: Phasebio Pharmaceuticals. 60: $10.9 M: …See details»
Landos Biopharma, Inc. Company Profile: , Investments, Contact ...
Landos Biopharma is a clinical stage biopharmaceutical company focused on the development of first-in-class therapeutics for patients with autoimmune disease. The Company’s mission is to …See details»
Landos Biopharma CEO and Key Executive Team | Craft.co
Landos Biopharma's Director is Tim M. Mayleben. Other executives include Gregory Oakes, President and CEO; Andrew Leber, Scientific Director and 2 others. See the full leadership …See details»
Landos Biopharma Announces Leadership Transition - Yahoo …
Nov 8, 2021 Josep Bassaganya-Riera Steps Down as Chairman, President and CEO Tim M. Mayleben Appointed Interim President and CEO Chris Garabedian Appointed Chairman of the …See details»
www.landosbiopharma.org
Www.landosbiopharma.orgSee details»
Landos Biopharma to Host Corporate Update Call
BLACKSBURG, Va., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Landos Biopharma Inc. (NASDAQ: LABP) today announced that it will report third quarter 2021 financial results and host a …See details»